Home 2020.

Thank you for attending the ASCEPT-APSA 2020 Joint Virtual Scientific Meeting.

On behalf of the Organising Committee, we thank you for attending the ASCEPT- APSA 2020 Joint Virtual Scientific Meeting on 24 – 26 November 2020.

The theme for this meeting was: Global solutions for global challenges

We hope you found the meeting both professionally and personally rewarding and look forward to seeing you next year at the 2021 meeting.

All presentation recordings have now been uploaded to the virtual meeting portal and will be available for viewing up until Friday 11 December 2020.

Thank you for your continued interest and your support of both ASCEPT and APSA.

ASCEPT-APSA 2020 Organising Committee

Dr Dan Wright ASCEPT Co-chair	Dr Jonathan Penm APSA Co-chair

Who should attend:
The conference is open to members and non-members from related disciplines, and is relevant for:

o Scientists from academia and industry who are involved in drug discovery, drug formulation and drug delivery research and development
o Researchers in the fields of neuropharmacology, cardiovascular pharmacology, respiratory and inflammatory disease pharmacology, urogenital and gastrointestinal pharmacology, toxicology, pharmacogenomics and pharmacoepidemiology.
o Regulatory and clinical scientists involved in bioavailability and bioequivalence study design and assessment, preparation and review of regulatory dossiers
o Researchers and clinicians in the clinical and practice areas of pharmacy
o Academics and researchers and with an interest in pharmacy education
o Government agencies involved in chemical safety assessment and registration
o Medical practitioners such as clinical pharmacologists, clinical toxicologists, cardiologists and general physicians.
o Students and postdoctoral fellows from all areas of pharmacology, toxicology, pharmacy practice, pharmacy education and pharmaceutical sciences.

Thank you for attending ASCEPT-PAGANZ 2019 Joint Scientific Meeting

On behalf of the Program Committee, we thank you for attending the ASCEPT- PAGANZ 2019 Joint Scientific Meeting that was held at Rydges Lakeland Resort, Queenstown, New Zealand from 25 – 29 November 2019.

The theme for this meeting was: Shared horizons: Optimising drug response to improve patient outcomes

With over 250 attendees at the Meeting from Australia, New Zealand, Asia, Europe and the United States.

We hope you found the conference both professionally and personally rewarding and look forward to seeing you at the next conference.

Dr Wendy Imlach, ASCEPT Co-chair	Assoc Prof David Foster, PAGANZ Co-chair

Who should attend:

• academic and industrial scientists associated with drug discovery, drug formulation and drug delivery research and development
• clinicians involved in the prescription and/or review of therapeutic agents
• regulatory and clinical scientists involved in drug development and drug registration, bioavailability and bioequivalence study design and assessment, preparation and review of regulatory dossiers
• researchers in clinical pharmacy, pharmacology and toxicology
• education providers in pharmacy, pharmacology and toxicology
• students and postdoctoral fellows from Australia and New Zealand in all areas of pharmaceutical science and pharmacy
• government agencies involved in chemical safety assessment and registration
• medical practitioners such as clinical pharmacologists, clinical toxicologists, cardiologists and general physicians.

Welcome to the ASCEPT 2013 Annual Scientific Meeting

On behalf of the ASCEPT Program Committee, I invite you to attend the ASCEPT 2013 Annual Scientific Meeting to be held at the RACV City Club, Melbourne from 1 to 4 December 2013. This meeting is the major gathering of academics and researchers in the fields of clinical and experimental pharmacology and clinical and experimental toxicology across Australia and New Zealand. The theme for the meeting is Breaking down the silos – academia, industry and the government collaboratively developing medicines.

We believe this important meeting will be an excellent opportunity to showcase the world class research undertaken by ASCEPT members. Importantly, this meeting offers the opportunity to network with colleagues and other leading international and national scientists and academics at both social and scientific activities. A key feature of the meeting is the chance for early career researchers and research students to present their research findings in poster and oral presentations sessions. Annual awards and prizes from ASCEPT will also be presented at this meeting.

The program of plenary lectures, symposia and workshops, oral presentations and posters will be scientifically stimulating and lead to new collaborations and research opportunities.

Our international guests include Dr Joga Gobburu, Dr Masamitsu Iimo and Dr John Warren.

We look forward to welcoming you to Melbourne.

Prof David Le Couteur ASCEPT President	Prof Dom Geraghty Co-chair, Program Committee	Prof Carl Kirkpatrick Co-chair, Program Committee

Who should attend:
• academic and industrial scientists associated with discovery, formulation and the delivery of drugs
• clinicians involved in the prescription and/or review of therapeutic agents
• regulatory and clinical scientists involved in drug development and drug registration
• researchers in clinical pharmacy, pharmacology and toxicology
• education providers in pharmacy, pharmacology and toxicology
• students and postdoctoral fellows from Australia and New Zealand in all areas of the pharmaceutical sciences
• government agencies involved in chemical safety assessment and registration
• medical practitioners such as clinical pharmacologists, clinical toxicologists, cardiologists and general physicians.

Thank you to the following key sponsors of the 2013 conference:

Major sponsor	Bronze sponsors